Stay updated on Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:53:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding lapse and operating status notice from the page. The study details, eligibility criteria, locations, and results plan remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:36:18.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The Study Details page content appears unchanged between the two screenshots.
    Difference
    0.4%
    Check dated 2025-10-27T21:08:31.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T08:58:13.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release.
    Difference
    0.1%
    Check dated 2025-09-29T07:30:43.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the Back to Top element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T23:19:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.